J, S., HR, S., TA, Y., M, L., PJ, W., A, C., . . . I, A. (2021). An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: The HALT LTBI pilot study.
Citación estilo ChicagoJ, Surey, et al. An Open Label, Randomised Controlled Trial of Rifapentine Versus Rifampicin Based Short Course Regimens for the Treatment of Latent Tuberculosis in England: The HALT LTBI Pilot Study. 2021.
Cita MLAJ, Surey, et al. An Open Label, Randomised Controlled Trial of Rifapentine Versus Rifampicin Based Short Course Regimens for the Treatment of Latent Tuberculosis in England: The HALT LTBI Pilot Study. 2021.
Precaución: Estas citas no son 100% exactas.